{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T17:01:40Z","timestamp":1740157300072,"version":"3.37.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T00:00:00Z","timestamp":1670976000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T00:00:00Z","timestamp":1670976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["5U54GM104942-05"],"award-info":[{"award-number":["5U54GM104942-05"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Addict Sci Clin Pract"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Medication for opioid use disorder (MOUD) includes administering medications such as buprenorphine or methadone, often with mental health services. MOUD has been shown to significantly improve outcomes and success of recovery from opioid use disorder. In WV, only 18% of providers including physicians, physician assistants, and nurse practitioners are waivered, and 44% of non-waivered providers were not interested in free training even if compensated. This exploratory research seeks to understand intervention-related stigma in community-based primary care providers in rural West Virginia, determine whether financial incentives for training may be linked to levels of stigma, and what level of financial incentives would be required for non-adopters of MOUD services provision to obtain training.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>Survey questions were included in the West Virginia Practice-Based Research Network (WVPBRN) annual Collective Outreach &amp; Research Engagement (CORE) Survey and delivered electronically to each practice site in WV. General demographic, staff attitudes and views on compensation for immersion training for delivering MOUD therapy in primary care offices were returned. Statistical analysis included logistic and multinomial logistic regression and an independent samples t-test.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Data were collected from 102 participants. Perceived stigma did significantly predict having a waiver with every 1-unit increase in stigma being associated with a 65% decreased odds of possessing a waiver for buprenorphine\/MOUD (<jats:italic>OR<\/jats:italic>\u2009=\u20090.35; 95% CI\u2009\u20090.16\u20130.78, <jats:italic>p<\/jats:italic>\u2009=\u20090.01). Further, t-test analyses suggested there was a statistically significant mean difference in perceived stigma (<jats:italic>t<\/jats:italic>(100)\u2009=\u20092.78, <jats:italic>p<\/jats:italic>\u2009=\u20090.006) with those possessing a waiver (<jats:italic>M<\/jats:italic>\u2009=\u20091.56; <jats:italic>SD<\/jats:italic>\u2009=\u20090.51) having a significantly lower perceived stigma than those without a waiver (<jats:italic>M<\/jats:italic>\u2009=\u20091.92; <jats:italic>SD<\/jats:italic>\u2009=\u20090.57). There was no statistically significant association of stigma on whether someone with a waiver actually prescribed MOUD or not (<jats:italic>OR<\/jats:italic>\u2009=\u20090.28; 95% CI\u2009\u20090.04\u20132.27, <jats:italic>p<\/jats:italic>\u2009=\u20090.234).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This survey of rural primary care providers demonstrates that stigmatizing beliefs related to MOUD impact the desired financial incentive to complete a one-day immersion, and that currently unwaivered providers endorse more stigmatizing beliefs about MOUD when compared to currently waivered providers. Furthermore, providers who endorse stigmatizing beliefs with respect to MOUD require higher levels of compensation to consider such training.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13722-022-00353-y","type":"journal-article","created":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T08:03:09Z","timestamp":1671004989000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Exploring the question of financial incentives for training amongst non-adopters of MOUD in rural primary care"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8327-686X","authenticated-orcid":false,"given":"Treah","family":"Haggerty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas A.","family":"Turiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tyra","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Dekeseredy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cara L.","family":"Sedney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,14]]},"reference":[{"issue":"5","key":"353_CR1","doi-asserted-by":"publisher","first-page":"293","DOI":"10.7326\/M17-0865","volume":"167","author":"B Han","year":"2017","unstructured":"Han B, Comptom WM, Blanco C, Crane E, Lee J, Jones CM. Prescription opioid use, misuse, and use disorders in US adults: 2015 national survey on drug use and health. Ann Intern Med. 2017;167(5):293\u2013301.","journal-title":"Ann Intern Med"},{"issue":"1","key":"353_CR2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.biopsych.2019.06.020","volume":"87","author":"J Bell","year":"2020","unstructured":"Bell J, Strang J. Medication treatment of opioid use disorder. Biol Psychiatry. 2020;87(1):82\u20138.","journal-title":"Biol Psychiatry"},{"key":"353_CR3","doi-asserted-by":"publisher","first-page":"116712","DOI":"10.1016\/j.jns.2020.116712","volume":"411","author":"LR Lander","year":"2020","unstructured":"Lander LR, Zheng W, Hustead JD, Mahoney JJ, Berry JH, Marshalek P, et al. Long-term treatment retention in West Virginia\u2019s comprehensive opioid addiction treatment (COAT) program. J Neurol Sci. 2020;411:116712.","journal-title":"J Neurol Sci"},{"key":"353_CR4","unstructured":"National academies of sciences engeneering and medicine. Medications for opioid use disorder save lives. 2019."},{"issue":"5","key":"353_CR5","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1001\/archpsyc.58.5.503","volume":"58","author":"Y Hser","year":"2001","unstructured":"Hser Y, Hoffman V, Grella C, Anglin MD. A 33-year follow-up of narcotic addicts. Arch Gen Psychiatry. 2001;58(5):503\u20138.","journal-title":"Arch Gen Psychiatry"},{"key":"353_CR6","unstructured":"National institute on drug abuse. Methadone and buprenorphine reduce risk of death after opioid overdose. New releases. 2018 .\u00a0\u00a0https:\/\/www.drugabuse.gov\/news-events\/news-releases\/2018\/06\/methadone-and-buprenorphine-reduce-risk-of-death-after-opioid-overdose. Accessed 1\u00a0Jul 2020."},{"key":"353_CR7","unstructured":"Substance abuse and mental health services administration (SAMHSA). MAT medications, counseling, and related conditions. 2020 .\u00a0\u00a0https:\/\/www.samhsa.gov\/medication-assisted-treatment\/medications-counseling-related-conditions. Accessed\u00a01\u00a0Jul 2020."},{"key":"353_CR8","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.drugalcdep.2016.04.039","volume":"164","author":"M Vogel","year":"2016","unstructured":"Vogel M, Nordt C, D\u00fcrsteler KM, Lang UE, Seifritz E, Krausz M, et al. Evaluation of medication-assisted treatment of opioid dependence-the physicians\u2019 perspective. Drug Alcohol Depend. 2016;164:106\u201312.","journal-title":"Drug Alcohol Depend"},{"key":"353_CR9","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2149","volume":"166","author":"PT Korthuis","year":"2017","unstructured":"Korthuis PT, McCarty D, Weimer M, Bougatsos C, Blazina I, Zakher B, et al. Primary care\u2013based models for the treatment of opioid use disorder. Ann Intern Med. 2017;166:268\u201378.","journal-title":"Ann Intern Med"},{"issue":"2","key":"353_CR10","first-page":"32","volume":"3","author":"AB Sheppard","year":"2021","unstructured":"Sheppard AB, Young JC, Davis SM, Moran GE. Perceived ability to treat opioid use disorder in West Virginia. J Appalach Heal. 2021;3(2):32.","journal-title":"J Appalach Heal"},{"key":"353_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102704","author":"EL Richard","year":"2020","unstructured":"Richard EL, Schalkoff CA, Piscalko HM, Brook DL, Sibley AL, Lancaster KE, et al. \u201cYou are not clean until you\u2019re not on anything\u201d: perceptions of medication-assisted treatment in rural Appalachia. Int J Drug Policy. 2020. https:\/\/doi.org\/10.1016\/j.drugpo.2020.102704.","journal-title":"Int J Drug Policy."},{"key":"353_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15332640.2020.1725290","volume":"19","author":"JG Salvador","year":"2020","unstructured":"Salvador JG, Bhatt SR, Jacobsohn V, Maley LA, Alkhafaji RS, Rishel Brakey H, et al. Feasibility and acceptability of an online ECHO intervention to expand access to medications for treatment of opioid use disorder, psychosocial treatments and supports. Subst Abus. 2020;19:1\u20138.","journal-title":"Subst Abus"},{"issue":"3","key":"353_CR13","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1080\/00952990.2019.1694536","volume":"46","author":"JJ Lister","year":"2020","unstructured":"Lister JJ, Weaver A, Ellis JD, Himle JD, Ledgerwood DM. A systematic review of rural-specific barriers to medication treatment for opioid use disorder in the United States. Am J Drug Alcohol Abuse. 2020;46(3):273\u201388.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"353_CR14","unstructured":"West Virginia department of health and human services. Division of primary care. state agency directory\/online services.\u00a0\u00a0https:\/\/dhhr.wv.gov\/dpc\/primarycare\/Pages\/default.aspx. Accessed\u00a019\u00a0Oct\u00a02022."},{"key":"353_CR15","unstructured":"The Robert graham center. Policy studies in family medicine and primary care. West Virginia state profile of primary care workforce and social determinants of health.\u00a0https:\/\/www.aafp.org\/dam\/rgc\/documents\/publications-reports\/monographs-books\/WestVirginiaPrimaryCareSocialDetHealth.pdf. Accessed 29 Mar 2022."},{"key":"353_CR16","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.socscimed.2019.05.027","volume":"232","author":"EF Madden","year":"2019","unstructured":"Madden EF. Intervention stigma: how medication-assisted treatment marginalizes patients and providers. Soc Sci Med. 2019;232:324\u201331.","journal-title":"Soc Sci Med"},{"key":"353_CR17","unstructured":"West Virginia clinical and translational science institute. The West Virginia practice-based research network . Network membership as of 4\/2019. 2019.\u00a0https:\/\/www.wvctsi.org\/media\/12947\/member-info-sheet-4-2019.pdf. Accessed 29 Mar 2022."},{"key":"353_CR18","unstructured":"West Virginia clinical and translational science institute. WVPBRN CORE survey. resources and services.\u00a0https:\/\/www.wvctsi.org\/programs\/community-engagement-outreach\/practice-based-research-network\/wvpbrn-core-survey\/. Accessed 2 Feb 2022."},{"issue":"4","key":"353_CR19","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.evalprogplan.2011.02.004","volume":"34","author":"HK Knudsen","year":"2011","unstructured":"Knudsen HK, Abraham AJ, Oser CB. Barriers to the implementation of medication-assisted treatment for substance use disorders: the importance of funding policies and medical infrastructure. Eval Program Plann. 2011 Nov;34(4):375\u201381.","journal-title":"Eval Program Plann"},{"key":"353_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s40359-015-0089-9","author":"MS Bauer","year":"2015","unstructured":"Bauer MS, Damschroder L, Hagedorn H, Smith J, Kilbourne AM. An introduction to implementation science for the non-specialist. BMC Psychol. 2015. https:\/\/doi.org\/10.1186\/s40359-015-0089-9.","journal-title":"BMC Psychol"},{"issue":"2","key":"353_CR21","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.annemergmed.2020.02.020","volume":"76","author":"SD Foster","year":"2020","unstructured":"Foster SD, Lee K, Edwards C, Pelullo AP, Khatri UG, Lowenstein M, et al. Providing incentive for emergency physician X-Waiver training: an evaluation of program success and postintervention buprenorphine prescribing. Ann Emerg Med. 2020;76(2):206\u201314.","journal-title":"Ann Emerg Med"},{"issue":"12","key":"353_CR22","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1001\/jama.2021.1741","volume":"325","author":"Y Olsen","year":"2021","unstructured":"Olsen Y, Fitzgerald RM, Wakeman SE. Overcoming barriers to treatment of opioid use disorder. JAMA. 2021;325(12):1149\u201350.","journal-title":"JAMA"},{"issue":"1","key":"353_CR23","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1080\/08897077.2021.1944957","volume":"43","author":"B Andraka-Cristou","year":"2022","unstructured":"Andraka-Cristou B, Totaram R, Randall-Kosich O. Stigmatization of medications for opioid use disorder in 12-step support groups and participant responses. Subst Abus. 2022;43(1):415\u201324.","journal-title":"Subst Abus"},{"issue":"1","key":"353_CR24","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1080\/08897077.2021.1917475","volume":"43","author":"MJN Tiako","year":"2022","unstructured":"Tiako MJN, Mszar R, Brooks 2nd C, Mahmood SU, Bin, Mori M, Vallabhajosyula P, et al. Cardiac surgeons\u2019 practices and attitudes toward addiction care for patients with substance use disorders. Subst Abus. 2022;43(1):206\u201311.","journal-title":"Subst Abus"},{"key":"353_CR25","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.drugpo.2018.04.004","volume":"57","author":"CE Paquette","year":"2018","unstructured":"Paquette CE, Syvertsen JL, Pollini RA. Stigma at every turn: health services experiences among people who inject drugs. Int J Drug Policy. 2018;57:104\u201310.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"353_CR26","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s13181-015-0517-5","volume":"12","author":"E Salsitz","year":"2016","unstructured":"Salsitz E, Wiegand T. Pharmacotherapy of opioid addiction: \u201cputting a real face on a false demon. J Med Toxicol. 2016;12(1):58\u201363.","journal-title":"J Med Toxicol"},{"key":"353_CR27","first-page":"1","volume":"13","author":"J-D Bacsu","year":"2021","unstructured":"Bacsu J-D, Johnson S, O\u2019connell ME, Viger M, Muhajarine N, Hackett P, et al. Stigma reduction interventions of dementia: a scoping review. Can J Aging. 2021;13:1\u201311.","journal-title":"Can J Aging"},{"key":"353_CR28","doi-asserted-by":"publisher","first-page":"112852","DOI":"10.1016\/j.socscimed.2020.112852","volume":"250","author":"BA Kohrt","year":"2020","unstructured":"Kohrt BA, Turner EL, Rai S, Bhardwaj A, Sikkema KJ, Adelekun A, et al. Reducing mental illness stigma in healthcare settings: proof of concept for a social contact intervention to address what matters most for primary care providers. Soc Sci Med. 2020;250:112852.","journal-title":"Soc Sci Med"},{"issue":"3","key":"353_CR29","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/inm.12578","volume":"28","author":"C Mart\u00ednez-Mart\u00ednez","year":"2019","unstructured":"Mart\u00ednez-Mart\u00ednez C, Sanchez-Martinez V, Sales-Orts R, Dinca A, Richart-Martinez M, Ramos-Pichardo JD. Effectiveness of direct contact intervention with people with mental illness to reduce stigma in nursing students. Int J Ment Health Nurs. 2019;28(3):735\u201343.","journal-title":"Int J Ment Health Nurs"},{"key":"353_CR30","doi-asserted-by":"publisher","first-page":"112641","DOI":"10.1016\/j.psychres.2019.112641","volume":"284","author":"D Mittal","year":"2020","unstructured":"Mittal D, Owen RR, Ounpraseuth S, Chekuri L, Drummond KL, Jennings MB, et al. Targeting stigma of mental illness among primary care providers: findings from a pilot feasibility study. Psychiatry Res. 2020;284:112641.","journal-title":"Psychiatry Res"},{"key":"353_CR31","doi-asserted-by":"publisher","first-page":"616729","DOI":"10.3389\/fpsyg.2021.616729","volume":"12","author":"AJ Clinton","year":"2021","unstructured":"Clinton AJ, Pollini RA. Using positive empathy interventions to reduce stigma toward people who inject drugs. Front Psychol. 2021;12:616729.","journal-title":"Front Psychol"},{"issue":"5","key":"353_CR32","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/j.1360-0443.2007.01766.x","volume":"102","author":"T Coleman","year":"2007","unstructured":"Coleman T, Lewis S, Hubbard R, Smith C. Impact of contractual financial incentives on the ascertainment and management of smoking in primary care. Addiction. 2007;102(5):803\u20138.","journal-title":"Addiction"},{"key":"353_CR33","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jpeds.2020.03.016","volume":"226","author":"A Guttmann","year":"2020","unstructured":"Guttmann A, Saunders NR, Kumar M, Gandhi S, Diong C, MacCon K, et al. Implementation of a physician incentive program for 18-month developmental screening in ontario. Canada J Pediatr. 2020;226:213-220.e.1.","journal-title":"Canada. J Pediatr"},{"issue":"11","key":"353_CR34","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1007\/s11606-021-06803-8","volume":"36","author":"JA Staples","year":"2021","unstructured":"Staples JA, Liu G, Brubacher JR, Karimuddin A, Sutherland JM. Physician financial incentives to reduce unplanned hospital readmissions: an interrupted time series analysis. J Gen Intern Med. 2021;36(11):3431\u201340.","journal-title":"J Gen Intern Med"},{"key":"353_CR35","doi-asserted-by":"publisher","first-page":"114045","DOI":"10.1016\/j.socscimed.2021.114045","volume":"281","author":"M Swami","year":"2021","unstructured":"Swami M, Scott A. Impact of rural workforce incentives on access to GP services in underserved areas: evidence from a natural experiment. Soc Sci Med. 2021;281:114045.","journal-title":"Soc Sci Med"}],"container-title":["Addiction Science &amp; Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-022-00353-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13722-022-00353-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-022-00353-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T08:15:03Z","timestamp":1671005703000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpjournal.biomedcentral.com\/articles\/10.1186\/s13722-022-00353-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,14]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["353"],"URL":"https:\/\/doi.org\/10.1186\/s13722-022-00353-y","relation":{},"ISSN":["1940-0640"],"issn-type":[{"type":"electronic","value":"1940-0640"}],"subject":[],"published":{"date-parts":[[2022,12,14]]},"assertion":[{"value":"29 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The West Virginia University Institutional Review Board approved this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors report no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"72"}}